Related Experiment Video
Updated: May 7, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Inhibition of p38 activity reverses claudin-6 induced cell apoptosis, invasion, and migration
Qiong Wu1, Xing Liu, Ya-Fang Liu
1Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin 130021, China.
Background:
Claudin-6 is a protein component of tight junctions and its expression could downregulate the malignant phenotype of breast carcinoma. Here we investigated the mechanisms of claudin-6 induced human MCF-7 breast cancer cells apoptosis, invasion, and migration.
Methods:
Terminal deoxyribonucleotide transferase-mediated nick-end labeling assay and Annexin-V/PI double stain assay were carried out to evaluate apoptosis. Inhibitors of each pathway were used to inactivate the signaling pathways. The expression of claudin-6 and phosphate p38, Erk 1/2 and Akt protein levels was confirmed by Western blotting analysis. Invasive and migratory traits of claudin-6 expressing cells were determined by Boyden chamber invasion assay and monolayer wound-healing assay.
Results:
Cells with high-level expression of claudin-6 had a higher rate of apoptosis than control cells. Western blotting assay showed that by contrast to control groups, p38 pathways were more activated in claudin-6 expressing cells. However, after inhibitor SB203580 treatment, the activation status could be significantly counteracted. Furthermore, by applying inhibitors to the apoptotic rate, invasive and migratory traits were also recovered in cells with claudin-6 expression.
Conclusion:
Claudin-6 may function through p38 mitogen-activated protein kinase pathway, of which inhibition may reverse claudin-6-induced cell apoptosis, invasion, and migration.
Insights
Claudin-6 expression induces apoptosis and reduces invasion in breast cancer cells by activating the p38 pathway. Inhibiting this pathway reverses these effects, suggesting a therapeutic target.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Claudin-6 is a tight junction protein potentially suppressing breast cancer malignancy.
- Investigated mechanisms of claudin-6 in regulating cancer cell apoptosis, invasion, and migration.
Purpose of the Study:
- To elucidate the role of claudin-6 in breast cancer cell apoptosis, invasion, and migration.
- To identify the specific signaling pathways involved in claudin-6's effects.
Main Methods:
- Apoptosis assessed via TUNEL and Annexin-V/PI assays.
- Western blotting used to analyze protein expression (claudin-6, p38, Erk1/2, Akt).
- Invasion and migration evaluated using Boyden chamber and wound-healing assays, respectively.
Main Results:
- High claudin-6 expression correlated with increased apoptosis.
- Claudin-6 upregulated p38 mitogen-activated protein kinase (MAPK) pathway activation.
- Inhibition of p38 MAPK reversed claudin-6-induced apoptosis, invasion, and migration.
Conclusions:
- Claudin-6 exerts its effects on breast cancer cells, including apoptosis and reduced motility, via the p38 MAPK pathway.
- Inhibiting the p38 MAPK pathway may offer a strategy to counteract claudin-6's tumor-suppressive functions.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Abnormal Proliferation

